Junqing Hou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 4
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Co-authors
- Xinyi Du (5 shared papers)Junkai Chang (7 shared papers)Weibo Xu (7 shared papers)Zhenhua Zhao (8 shared papers)Wenchao Xu (4 shared papers)Xiaolei Zhao (5 shared papers)Hui Liu (3 shared papers)Xiaobo Nie (7 shared papers)
- Journals
- BMC Public Health (2 papers)BMC Cancer (2 papers)DNA and Cell Biology (1 paper)Biochemical Pharmacology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Junqing Hou
22 papers receiving 449 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 246
- Molecular Biology 254
- Pulmonary and Respiratory Medicine 62
- Oncology 49
- Biochemistry 11
Countries citing papers authored by Junqing Hou
This map shows the geographic impact of Junqing Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Hou more than expected).
Fields of papers citing papers by Junqing Hou
This network shows the impact of papers produced by Junqing Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Hou. The network helps show where Junqing Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Junqing Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 78 | |
| 2 | 2018 | 63 | |
| 3 | Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. | 2015 | 61 |
| 4 | Down-regulation of miR-497 is associated with poor prognosis in renal cancer. | 2015 | 43 |
| 5 | 2016 | 35 | |
| 6 | 2020 | 34 | |
| 7 | 2024 | 26 | |
| 8 | 2023 | 25 | |
| 9 | 2020 | 19 | |
| 10 | 2018 | 13 | |
| 11 | 2017 | 13 | |
| 12 | 2024 | 9 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2024 | 5 | |
| 16 | [Clinical observation on effect of Aidi injection in treating radiation injury of lung]. | 2004 | 5 |
| 17 | 2024 | 3 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2017 | 1 |
About Junqing Hou
Junqing Hou is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Oncology, having authored 25 papers that have together received 451 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), Prostate Cancer Treatment and Research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (246 citations), Molecular Biology (254 citations), Pulmonary and Respiratory Medicine (62 citations), Oncology (49 citations) and Biochemistry (11 citations). Junqing Hou has collaborated with scholars based in China. Frequent co-authors include Xinyi Du, Junkai Chang, Weibo Xu, Zhenhua Zhao, Wenchao Xu, Xiaolei Zhao, Hui Liu, Xiaobo Nie, Yifan Hou and Gang Xia. Their work appears in journals such as BMC Public Health, BMC Cancer, DNA and Cell Biology, Biochemical Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.